PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

Friday, November 15, 2019

REGULATORY AFFAIRS


Newsletter

REGULATORY AFFAIRS from The Pharmaceutical Marketing Group is a regular email newsletter, sharing appointments on the pharmaceutical industry

Direct to your inbox

Stay up to date with the latest appointments by subscribing to LOOK WHO IS ON THE MOVE! from The Pharmaceutical Marketing Group

View the newsletter archive

Merck’s ERVEBO® [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the...

Sonde Health Granted Foundational U.S. Patent for Use of Vocal Biomarkers in Health Assessments

BOSTON--(BUSINESS WIRE)--Sonde Health, Inc., a leading company developing a...

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19

AUSTIN, Texas & HAMILTON, Ontario--(BUSINESS WIRE)--Triumvira Immunologics, Inc. (Triumvira),...

Sesen Bio Announces Successful Type C Meeting with FDA for Vicinium

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical...

Seattle Genetics Responds to Daiichi Sankyo’s Complaint for Declaratory Judgment

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) today released the...

CANbridge Receives Hong Kong Department of Health Market Approval for NERLYNX®

BEIJING--(BUSINESS WIRE)--CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative...

Bionomics Announces Fast Track Designation Granted by U.S. FDA to BNC210 Development Program for the Treatment of PTSD

MELBOURNE, Australia--(BUSINESS WIRE)--Bionomics Limited (ASX:BNO, OTCQX:BNOEF), a global, clinical...